Novo Integrated Sciences Inc. (NVOS) has had a mixed performance in recent times, with the stock receiving mixed ratings from analysts. Its capital structure generated 31.25 points at debt to equity, with total debt to capital at 23.81, and long-term debt to equity ratio at 18.67. NVOS has a debt to enterprise value of 0.27, with a receivables turnover of 4.31 and a liquidity ratio of 1.32.
The company’s total debt to assets ratio is 22.13, and the long-term debt to capital ratio is at 14.23. Additionally, NVOS’s stock has experienced volatility, with a decline in its stock price by -6.54 compared to its previous closing price. Despite this, the company has seen an 18.34% gain in its stock.
Finally, NVOS is trading at a significant distance from its 50-day moving average and 52-week high.
Novo Integrated Sciences Inc. (NVOS) has seen a decline in its stock price by -6.54 compared to its previous closing price of 0.13. Despite this, the company has experienced a 18.34% gain in its stock. The public float for NVOS is 12.54M, and currently, short sellers hold a 33.27% ratio of that float. The average trading volume of NVOS on March 28, 2023, was 28.57M shares.
NVOS’s market performance has been volatile in recent times. The stock has seen an 18.34% increase in the past week, with a 7.24% rise in the past month, and a -39.24% fall in the past quarter. The volatility ratio for the week is 17.05%, and the volatility levels for the past 30 days are at 17.30% for NVOS. The simple moving average for the last 20 days is -11.02% for NVOS stock, with a simple moving average of -85.37% for the last 200 days.
NVOS is currently trading at -7.47% from the 50-Day Moving Average. After a stumble in the market that brought NVOS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.54% of loss for the given period. The volatility rate increased by 17.05% over the last 30 days, as shares surged +3.90% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.58% lower at present.
Reports indicate that there were more than several insider trading activities at NVOS, starting from Oliva Robert Letterio, who purchased 5,000 shares at the price of $2.23 back on Apr 20. After this action, Oliva Robert Letterio now owns 217,717 shares of Novo Integrated Sciences Inc., valued at $11,156 using the latest closing price. Oliva Robert Letterio, the Director of Novo Integrated Sciences Inc., purchased 5,000 shares at $2.23 during a trade that took place back on Apr 19, which means that Oliva Robert Letterio is holding 212,717 shares at $11,125 based on the most recent closing price.
Finally, the current profitability levels for NVOS are not so good, with the present operating margin at -45.93 and the net margin standing at -47.95. The total capital return value is set at -9.34, while invested capital returns managed to touch -10.51. Equity return is now at value -28.00, with -18.40 for asset returns.
Novo Integrated Sciences Inc. (NVOS) has a capital structure that generated 31.25 points at debt to equity in total, with total debt to capital at 23.81. The total debt to assets ratio is 22.13, while the long-term debt to equity ratio is 18.67. Finally, the long-term debt to capital ratio stands at 14.23. NVOS has a debt to enterprise value settled at 0.27 and a receivables turnover of 4.31, with the total asset turnover ratio at 0.19. The liquidity ratio for NVOS is at 1.32.
In summary, NVOS has experienced mixed performance in recent times, with the stock receiving mixed ratings from analysts. It’s essential to note that the stock is trading at a significant distance from its 50-day moving average and 52-week high.
Don’t miss interesting posts on Famousbio
